These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27100731)

  • 21. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.
    Epstein JI; Feng Z; Trock BJ; Pierorazio PM
    Eur Urol; 2012 May; 61(5):1019-24. PubMed ID: 22336380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volume of Gleason pattern 4 stratifies risk of metastasis and death in patients with Gleason score 3+5=8/5+3=8 positive prostate core biopsies.
    Acosta AM; Taplin ME; Mata DA; D'Amico AV; Hirsch MS
    Hum Pathol; 2020 May; 99():62-74. PubMed ID: 32171650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
    Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
    Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up.
    Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG
    BJU Int; 2017 Nov; 120(5):651-658. PubMed ID: 28371244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.
    Pierorazio PM; Ross AE; Lin BM; Epstein JI; Han M; Walsh PC; Partin AW; Pavlovich CP; Schaeffer EM
    BJU Int; 2012 Oct; 110(8):1122-8. PubMed ID: 22373045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8.
    Manoharan M; Bird VG; Kim SS; Civantos F; Soloway MS
    BJU Int; 2003 Oct; 92(6):539-44. PubMed ID: 14511029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy].
    Zuo Q; Zhang F; Huang Y; Ma LL; Lu M; Lu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):603-606. PubMed ID: 29263497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution.
    Chen SD; Fava JL; Amin A
    Virchows Arch; 2016 Feb; 468(2):213-8. PubMed ID: 26563400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of the presence of tertiary Gleason grade 5 in robot-assisted radical prostatectomy specimens in Japanese patients with clinically localized prostate cancer.
    Kamoda N; Ohori M; Hirasawa Y; Inoue R; Hashimoto T; Satake N; Gondo T; Nakagami Y; Nagao T; Ohno Y
    Jpn J Clin Oncol; 2019 Mar; 49(3):276-280. PubMed ID: 30649377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of prospectively assigned Gleason tertiary pattern 4 in contemporary Gleason score 3+3=6 prostate cancer.
    Doshi C; Vacchio M; Attwood K; Murekeyisoni C; Mehedint DC; Badkhshan S; Azabdaftari G; Sule N; Guru KA; Mohler JL; Kauffman EC
    Prostate; 2016 Jun; 76(8):715-21. PubMed ID: 26880312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
    Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
    Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR; McNeal JE; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gleason Score ≤ 6 Prostate Cancer at Radical Prostatectomy: Does a High-Risk Setting Truly Exist? A Recursive Partitioning Analysis.
    Watkins JM; Mitchell DL; Russo JK; Mott SL; Tracy CR; Smith MC; Buatti JM
    Clin Genitourin Cancer; 2017 Apr; 15(2):242-247. PubMed ID: 27338519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6.
    Mehta V; Rycyna K; Baesens BM; Barkan GA; Paner GP; Flanigan RC; Wojcik EM; Venkataraman G
    Int J Clin Exp Pathol; 2012; 5(6):496-502. PubMed ID: 22949931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy.
    Thomsen FB; Folkvaljon Y; Brasso K; Loeb S; Robinson D; Egevad L; Stattin P
    J Surg Oncol; 2016 Nov; 114(6):664-670. PubMed ID: 27511833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6.
    Song W; Bang SH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Kim CK; Lee HM
    Clin Genitourin Cancer; 2018 Aug; 16(4):281-287. PubMed ID: 29550198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
    Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
    BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
    Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
    Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.